Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia.

ABSTRACT:

Importance

It has remained unclear whether there are clinically meaningful differences between antipsychotic treatments with regard to preventing relapse of schizophrenia, owing to the impossibility of including large unselected patient populations in randomized clinical trials, as well as residual confounding from selection biases in observational studies.

Objective

To study the comparative real-world effectiveness of antipsychotic treatments for patients with schizophrenia.

Design, setting, and participants

Prospectively gathered nationwide databases were linked to study the risk of rehospitalization and treatment failure from July 1, 2006, to December 31, 2013, among all patients in Sweden with a schizophrenia diagnosis who were 16 to 64 years of age in 2006 (29 82

SUBMITTER: Tiihonen J 

PROVIDER: S-EPMC5710250 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature